semaglutide merck Higher-Dose Injection Proves Mettle in Phase III Trials Eris Lifesciences introduces weekly shot

All FDA-approved GLP-1 medications carry important safety information, including contraindications for patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Extracellular nicotinamide phosphoribosyltransferase boosts IFN-induced macrophage polarization independently of TLR4

The group of researchers is now analyzing the data to see if those on GLP-1s who developed cancer have a significant difference in cancer outcomes compared with those with cancer but not taking a GLP-1

Semaglutide, originally developed for type 2 diabetes, has shown significant efficacy in weight reduction, which raises the question of its potential benefits for weight loss in patients with hypothyroidism